27
Jan
2020

Scientists at the Movies: Relay Therapeutics CEO Sanjiv Patel on The Long Run

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.

 
 

You may also like

Biologic Drug Discovery With AI: Sean McClain on The Long Run
A Long-Lasting Drug Against Flu: Jeff Stein on The Long Run
Precision Neuroscience for Epilepsy and More: Abe Ceesay on The Long Run
A New Outlook on Life With Sickle Cell Disease: Jimi Olaghere on The Long Run